Journal
PROSTATE
Volume 66, Issue 3, Pages 235-247Publisher
WILEY
DOI: 10.1002/pros.20340
Keywords
TGF-beta; adoptive transfer; gene therapy; CD8(+) T cell; immunosurveillance; tumor rejection
Categories
Funding
- NCI NIH HHS [CA107186] Funding Source: Medline
Ask authors/readers for more resources
BACKGROUND. TGF-beta is a potent immunosuppressant. High levels of TGF-beta produced by cancer cells have a negative inhibition effect on surrounding host immune cells and leads to evasion of the host immune surveillance and tumor progression. In the present study, we report a distinct ability of tumor reactive, TGF-beta-insensitive CD8(+) T cells to infiltrate into established tumors, secrete relevant cytokiries, and induce apoptosis of tumor cells. METHODS. CD8(+) T cells were isolated from the spleens of C57BL/6 mice, which were primed with irradiated mouse Prostate cancer cells, the TRAMP-C2 cells. After ex vivo expansion, these tumor reactive CD8(+) cells were rendered TGF-beta-insensitive by infection with a retroviral (MSCV)-mediated dominant negative TGF-beta type II receptor (T beta RIIDN). Control CD8(+) cells consist of those transfected with the GFP-only empty vector and naive CD8(+) T cells. Recipient mice were challenged witha single injection of TRAMP-C2 cells 21 days before adoptive transfer of CD8(+) T cells was performed. Forty days after the adoptive transfer, all animals were sacrificed. The presence of pulmonary metastases was evaluated pathologically. Serial slides of malignant tissues were used for immunofluorescent staining for different kinds of immune cell infiltration, cytokines, and apoptosis analysis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available